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background:  We aimed to study the changing demographics and outcomes in patients with diabetes presenting with ST elevation 
myocardial infarction (STEMI) over the last decade
methods:  We used the 2003-2011 US Nationwide Inpatient Sample for this study. All admissions with a principal diagnosis of STEMI were 
identified using standard ICD codes
Results:  Of a total of 379076 admissions with STEMI, we identified 96407 (25.4%) patients with diabetes. There was a significant increase 
in the proportion of diabetic patients from 24.1% in 2003 to 28.5% in 2011 (p-trend <0.001). Among diabetics, males increased from 58.6% 
in 2003 to 63.4% in 2011. Similarly, prevalence of obesity among diabetics increased from 11.9% in 2003 to 21.7% in 2011. Of all patients 
with STEMI, 31.1% of diabetics did not undergo revascularization as compared to 26.0% of non-diabetics (p<0.001). CABG was utilized 
as a revascularization modality in 10.3% of diabetics as compared to 8.2% among non-diabetics (p<0.001). Incidence of in-hospital death 
was significantly higher among diabetics (8.0%) as compared to non-diabetics (7.1%). In-hospital death rate among diabetics reduced from 
8.7% in 2003 to 7.1% in 2010, followed by a small increase to 7.8% in 2011. Among patients treated with revascularization, there was a 
significantly higher risk of adjusted mortality among diabetics as compared to non-diabetics [OR (95% CI): 1.13 (1.06-1.20)]. However, in-
hospital mortality rates between diabetics and non-diabetics not undergoing revascularization were similar. Besides this, diabetic patients 
with STEMI incurred longer stay and higher cost of hospitalization, as compared to non-diabetics. Median length of stay was 4 days among 
diabetics, as compared to 3 days among non-diabetics (p<0.001). Similarly, the cost of hospitalization among diabetics was $26227 as 
compared to $24774 among non-diabetics (p<0.001).
conclusion:  Among patients presenting with STEMI, diabetes was associated with a higher incidence of in-hospital death, longer hospital 
stay and a higher cost of hospitalization as compared to non-diabetics. There has been a significant change in demographics as well as 
outcomes following STEMI among diabetics over the last decade.
